DE60326757D1 - 1,4-DIAZABICYCLOi3.2.2 NONANECARBOXAMIDES DERIVATE, DEREN HERSTELLUNG, UND DEREN THERAPEUTISCHE VERWENDUNG IM ZUSAMMENHANG MIT NIKOTINISCHEN REZEPTOR-STÖRUNGEN - Google Patents

1,4-DIAZABICYCLOi3.2.2 NONANECARBOXAMIDES DERIVATE, DEREN HERSTELLUNG, UND DEREN THERAPEUTISCHE VERWENDUNG IM ZUSAMMENHANG MIT NIKOTINISCHEN REZEPTOR-STÖRUNGEN

Info

Publication number
DE60326757D1
DE60326757D1 DE60326757T DE60326757T DE60326757D1 DE 60326757 D1 DE60326757 D1 DE 60326757D1 DE 60326757 T DE60326757 T DE 60326757T DE 60326757 T DE60326757 T DE 60326757T DE 60326757 D1 DE60326757 D1 DE 60326757D1
Authority
DE
Germany
Prior art keywords
nonanecarboxamides
derivatives
preparation
connection
therapeutic use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60326757T
Other languages
English (en)
Inventor
Frederic Galli
Patrick Lardenois
Odile Leclerc
Alistair Lochead
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Aventis France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis France filed Critical Sanofi Aventis France
Application granted granted Critical
Publication of DE60326757D1 publication Critical patent/DE60326757D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE60326757T 2002-10-08 2003-10-06 1,4-DIAZABICYCLOi3.2.2 NONANECARBOXAMIDES DERIVATE, DEREN HERSTELLUNG, UND DEREN THERAPEUTISCHE VERWENDUNG IM ZUSAMMENHANG MIT NIKOTINISCHEN REZEPTOR-STÖRUNGEN Expired - Lifetime DE60326757D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0212500A FR2845388B1 (fr) 2002-10-08 2002-10-08 Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
PCT/FR2003/002929 WO2004033456A2 (fr) 2002-10-08 2003-10-06 Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique ayant trait au dysfonctionnement des recepteurs nicotiniques

Publications (1)

Publication Number Publication Date
DE60326757D1 true DE60326757D1 (de) 2009-04-30

Family

ID=32011522

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60326757T Expired - Lifetime DE60326757D1 (de) 2002-10-08 2003-10-06 1,4-DIAZABICYCLOi3.2.2 NONANECARBOXAMIDES DERIVATE, DEREN HERSTELLUNG, UND DEREN THERAPEUTISCHE VERWENDUNG IM ZUSAMMENHANG MIT NIKOTINISCHEN REZEPTOR-STÖRUNGEN

Country Status (9)

Country Link
EP (1) EP1575960B1 (de)
JP (1) JP4537853B2 (de)
AR (1) AR041527A1 (de)
AT (1) ATE425980T1 (de)
AU (1) AU2003283500A1 (de)
DE (1) DE60326757D1 (de)
FR (1) FR2845388B1 (de)
TW (1) TWI320413B (de)
WO (1) WO2004033456A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060120694A (ko) 2003-12-22 2006-11-27 메모리 파마슈티칼스 코포레이션 인돌, 1ｈ-인다졸, 1,2-벤즈이속사졸 및1,2-벤즈이소티아졸, 및 이들의 제법 및 용도
FR2865208B1 (fr) 2004-01-16 2009-01-16 Sanofi Synthelabo Derives de 1,4-diazabicyclo[3.2.1]octanecarboxmique, leur preparation et leur application en therapeutique
CA2560741C (en) 2004-03-25 2013-08-06 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
EP1742944B1 (de) * 2004-04-22 2010-11-10 Memory Pharmaceuticals Corporation Indole, 1h-indazole, 1,2-benzisoxazole, 1,2-benzoisothiazole, deren herstellung und verwendungen
JP2007538011A (ja) 2004-05-07 2007-12-27 メモリー・ファーマシューティカルズ・コーポレイション １ｈ−インダゾール、ベンゾチアゾール、１，２−ベンゾイソキサゾール、１，２−ベンゾイソチアゾール、およびクロモン、ならびにそれらの調製および使用
KR20070034049A (ko) 2004-06-09 2007-03-27 글락소 그룹 리미티드 피롤로피리딘 유도체
PL1828179T3 (pl) 2004-12-22 2010-08-31 Memory Pharm Corp Ligandy dla receptorów nikotynowych alfa-7 przeciwko chorobom związanym z OUN
JP2009514980A (ja) * 2005-11-09 2009-04-09 メモリー・ファーマシューティカルズ・コーポレイション １ｈ−インダゾール類、ベンゾチアゾール類、１，２−ベンゾイソオキサゾール類、１，２−ベンゾイソチアゾール類、および／クロモン類と、それらの製造と用途
EP1842541A1 (de) * 2006-03-29 2007-10-10 G.I.M.-Gesellschaft Für Innovative Medizin Gmbh Nfg Ohg Pflanzenextrakte, pflanzliche Wirkstoffe und ihre Verwendung
CA2703163A1 (en) * 2007-10-22 2009-04-30 Memory Pharmaceuticals Corporation (1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholine receptors, useful for the treatment of disease
JP2023553426A (ja) * 2020-12-08 2023-12-21 ディスアーム セラピューティクス， インコーポレイテッド Ｓａｒｍ１のベンゾピラゾール阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ226000A (en) * 1987-09-10 1991-06-25 Merck Sharp & Dohme Oxadiazolyl-azabicycloheptanes and pharmaceutical compositions
FR2786770B1 (fr) * 1998-12-04 2001-01-19 Synthelabo Derives de 1,4-diazabicyclo[3.2.2.]nonane, leur preparation et leur application en therapeutique
FR2804430B1 (fr) * 2000-01-28 2002-03-22 Sanofi Synthelabo Derives de 4-heteroaryl-1,4-diazabicyclo[3.2.2] nonane, leur preparation et leur application en therapeutique
FR2809730B1 (fr) * 2000-05-31 2002-07-19 Sanofi Synthelabo Derives de 1,4-diazabicyclo[3.2.2] nonanebenzoxazole, -benzothiazole et -benzimidazole, leur preparation et leur application therapeutique
US20020086871A1 (en) * 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders

Also Published As

Publication number Publication date
ATE425980T1 (de) 2009-04-15
AU2003283500A1 (en) 2004-05-04
TW200505926A (en) 2005-02-16
AU2003283500A8 (en) 2004-05-04
EP1575960B1 (de) 2009-03-18
TWI320413B (en) 2010-02-11
EP1575960A2 (de) 2005-09-21
WO2004033456A2 (fr) 2004-04-22
AR041527A1 (es) 2005-05-18
WO2004033456A3 (fr) 2004-05-27
JP4537853B2 (ja) 2010-09-08
JP2006506356A (ja) 2006-02-23
FR2845388B1 (fr) 2004-11-12
FR2845388A1 (fr) 2004-04-09

Similar Documents

Publication Publication Date Title
ATE395342T1 (de) 2-carbamid-4-phenylthiazol-derivate, deren herstellung und therapeutische verwendung
ATE294171T1 (de) Phenylsulfonyl-1,3-dihydro-2h-indol-2-on derivate,deren herstellung und deren therapeutische verwendung
DE50312295D1 (de) 8-ä3-amino-piperidin-1-ylü -xanthine, deren herstellung und deren verwendung als arzneimittel
DE60336907D1 (de) Spirobifluorenderivate, deren herstellung und deren verwendung
DE50312747D1 (de) Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel
ATE255569T1 (de) Indeno-, naphtho- und benzocyclohepta- dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
DE50015711D1 (de) In 6-stellung substituierte indolinone, ihre herstellung und ihre verwendung als arzneimittel
DE50209483D1 (de) Xanthinderivate, deren herstellung und deren verwendung als arzneimittel
ATE249460T1 (de) 1,4-diazabicyclo(3.2.2)nonanderivate, deren herstellung und deren verwendung in heilkunde
ATE372998T1 (de) 1-aminophthalazinderivate, deren herstellung und deren therapeutische verwendung
DE69915693D1 (de) 2,5-diazabicyclo(2.2.1)heptanderivate, deren herstellung und deren verwendung in heilkunde
DE60303440D1 (de) Benzoxazinonderivate, deren herstellung und deren verwendung als medikamente
ATE250045T1 (de) Indeno-dihydrothiazol derivate, deren herstellung und deren verwendung als anorektische arzneimittel
ATE417846T1 (de) Aminotropanderivate, deren herstellung und deren therapeutische verwendung
DE60307632D1 (de) Piperazinylacylpiperidinderivate, deren herstellung und deren therapeutische anwendung
DE60208044D1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
DE60326757D1 (de) 1,4-DIAZABICYCLOi3.2.2 NONANECARBOXAMIDES DERIVATE, DEREN HERSTELLUNG, UND DEREN THERAPEUTISCHE VERWENDUNG IM ZUSAMMENHANG MIT NIKOTINISCHEN REZEPTOR-STÖRUNGEN
ATE357448T1 (de) Benzoxazinonderivative, deren herstellung und verwendung
ATE261959T1 (de) Substituierte phenyl-piperazin-derivate, deren herstellung und verwendung
ATE242197T1 (de) 3-amino-3-arylpropan-1-ol-derivate, deren herstellung und verwendung
DE60005690D1 (de) Titanverbindungen, deren herstellung und verwendung
DE602004030564D1 (de) 2-substituierte phenyl-5,7-dialkyl-3,7-dihydropyrrolä2,3-dü pyrimidin-4-onderivate, deren herstellung und pharmazeutische verwendung
DE602004015600D1 (de) Neue imidazolderivative, deren herstellung und deren verwendung als medikament
ATE329908T1 (de) Arylethene-sulfonamid derivate, deren herstellung und deren verwendung als endothelin-antagonisten
ATE353325T1 (de) 4-heterocyclylsulfonamidyl-6-methoxy-5-(2-metho y-phenoxy)-2-pyridyl-pyrimidin derivate, deren herstellung und deren verwendung als endothelin rezeptor antagonisten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition